Company Name	Living Cell Technologies Limited
Registered Office	Living Cell Technologies Limited Level 3, 70 Pitt Street Sydney, NSW 2000 Australia (Effective from 1 June 2011)
Principal Place of Business	Australia Living Cell Technologies Limited Level 3, 70 Pitt Street Sydney, NSW 2000 Australia (Effective from 1 June 2011) New Zealand PO Box 23 566 Hunters Corner Manukau 2155 New Zealand
Locations	Corporate Office Sydney, Australia Operational Headquarters Auckland, New Zealand Other Locations Perugia, Italy Rhode Island, USA New York, U.S.A.
Sector	Life Science / Bio-Technology / Pharmaceutical
GICS Industry Group	Pharmaceuticals / Biotechnology & Life Sciences
Internet Homepage Address (URL)	http://www.lctglobal.com
Phone Number	(61) 2 9252 1933
Fax Number	(61) 2 9235 2709
Email Address	lct@lctglobal.com
Financial Year End	June 30
Board of Directors	Mr Roy Austin BCom, CA (Chairman) [Appointed on 20 July 2011], (Independent Director) Emeritus Professor Robert Elliott MBBS, MD, FRACP (Medical Director) Dr Bernie Tuch BSc, MBBS (Hons), FRACP and Ph D [Appointed on 20 July 2011] Mr Robert Willcocks BA, LLM (Independent Director) [Appointed on 29 March 2011] Mr Laurie Hunter MA (Hons) (Independent Director) Ms Susanne Clay (Alternate Director to Professor Robert Elliott) (Resigned on 11 July 2011) Dr Ross Macdonald (MD and CEO) (Resigned on 24 June 2011) Mr Bob Finder (Independent Director) (Resigned on 14 March 2011) Dr David Brookes (Independent Director) (Not re-elected at 18 November 2010 AGM) Mr Simon O'Loughlin (Director, Independent Director) (Not re-elected at 18 November 2010 AGM) Mr David McAuliffe (Independent Director) (Resigned on 18 November 2010) Dr Paul Tan [Resigned as Executive Director on 23 September 2010]
Management Team	Dr Andrea Grant PhD, BA (Hons) (Chief Executive Officer) (Effective from 16 January 2012) Emeritus Professor Robert Elliott MBBS, MD, FRACP (Medical Director) Mr John Cowan (Finance & Administration Manager) Dr Olga Garkavenko (Head of Research & Development) Mr Peter Hosking (Quality Assurance Manager) Ms Susanne Clay (Resigned as Chief Business Officer on 11 July 2011) Dr Ross Macdonald (Resigned as Chief Executive Officer on 24 June 2011) Dr Paul Tan [Resigned as Chief Executive Officer on 24 September 2010]
Company Secretary	Mr Nicholas Geddes
PR/IR Consultancy	Mr Allan Botica, Botica Butler Raudon
Principal Bankers	Westpac Banking Corporation Limited
Auditors	PKF Chartered Accountants & Business Advisers
Lawyers	Kemp Strang Level 16, 55 Hunter Street GPO Box 475 Sydney NSW 2001 Australia Greenberg Traurig LLP Met Life Building 200 Park Avenue New York, NY 10166 USA Jones Young PO Box 189 Shortland Street Auckland New Zealand AJ Park Level 14, AMP Centre 29 Customs Street West Auckland 1010 PO Box 565 Auckland 1140 New Zealand
Share Registry	Computershare Investor Services Pty Limited Level 5 , 115 Grenfell Street Adelaide, SA Australia, 5000
ASX Stock Code	LCT
Official Listing Date	1st September, 2004
ADR	LVCLY
OTCQX	LVCLY
Date of Listing on OTCQX	June 2008
Year LCT was Formed	2003
Market Capitalisation	A$45 M (As at 15 October 2010)
Total Ordinary Shares	273,999,851 (As of 30 June 2010)
Shares Held	USA - 18% Australia - 46% New Zealand - 20% Others - 16%
Outstanding Shares	283.8 M (ASX: 84%, OTCQX (ADR) :16%) (As at 15 July 2010 after options underwriting)
Outstanding Options	7.8% (As of 15 July 2010) (As percentage of outstanding shares)
Cash	$4,504,677 (As of 30 June 2011) [$3,468,825 (As of 31 March 2011]
Total Funds Raised	A$61 M
2010 Grant Highlights	New Zealand Government 2010 - NZ$4 M Juvenile Diabetes Research Foundation - US$0.5 M
ABN	14 104 028 042